- Home
- BNTC vs KIO Comparison
BNTC vs KIO Comparison
Compare BNTC & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNTC | KIO |
|---|---|---|
| Founded | 1995 | 2011 |
| Country | United States | United States |
| Employees | N/A | 2400 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 405.7M | 469.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BNTC | KIO |
|---|---|---|
| Price | $13.10 | $11.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $28.25 | N/A |
| AVG Volume (30 Days) | ★ 253.4K | 136.5K |
| Earning Date | 02-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 10.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.70 | $10.52 |
| 52 Week High | $17.15 | $13.59 |
Technical Indicators
Market Signals| Indicator | BNTC | KIO |
|---|---|---|
| Relative Strength Index (RSI) | 52.44 | 49.73 |
| Support Level | $10.99 | $11.55 |
| Resistance Level | $13.36 | $11.67 |
| Average True Range (ATR) | 0.94 | 0.09 |
| MACD | 0.15 | 0.01 |
| Stochastic Oscillator | 84.69 | 63.95 |
Price Performance
Historical ComparisonAbout BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.